rs749891883
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_015046.7(SETX):c.4828C>T(p.Leu1610Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,614,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015046.7 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 4Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- distal hereditary motor neuropathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015046.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SETX | NM_015046.7 | MANE Select | c.4828C>T | p.Leu1610Phe | missense | Exon 10 of 26 | NP_055861.3 | ||
| SETX | NM_001351528.2 | c.4828C>T | p.Leu1610Phe | missense | Exon 10 of 27 | NP_001338457.1 | |||
| SETX | NM_001351527.2 | c.4828C>T | p.Leu1610Phe | missense | Exon 10 of 26 | NP_001338456.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SETX | ENST00000224140.6 | TSL:1 MANE Select | c.4828C>T | p.Leu1610Phe | missense | Exon 10 of 26 | ENSP00000224140.5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152224Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251418 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461882Hom.: 0 Cov.: 33 AF XY: 0.0000578 AC XY: 42AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74378 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;C1865409:Amyotrophic lateral sclerosis type 4 Uncertain:1Benign:1
not specified Uncertain:1
Variant summary: SETX c.4828C>T (p.Leu1610Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 251418 control chromosomes, predominantly at a frequency of 0.00011 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SETX causing Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (4.8e-05 vs 0.0012), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.4828C>T in individuals affected with Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 574888). Based on the evidence outlined above, the variant was classified as uncertain significance.
Inborn genetic diseases Uncertain:1
The c.4828C>T (p.L1610F) alteration is located in exon 10 (coding exon 8) of the SETX gene. This alteration results from a C to T substitution at nucleotide position 4828, causing the leucine (L) at amino acid position 1610 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at